NCT05142644

Brief Summary

Intrauterine growth restriction (IUGR) is a pregnancy complication in about 3-5% of all pregnancies in Sweden. IUGR fetuses are at high risk of morbidity and death. The method used in Sweden to detect IUGR is repeated measurements of pregnant women's symphysis-fundus measure (SF measure). Weight estimation with ultrasound is performed only on indication; stagnant or deplaning SF dimensions or in the event of complications. Only high-risk pregnancies have repeated growth checks during pregnancy from the beginning. There are potential benefits to detecting IUGR fetuses during pregnancy. Still, the effect is questioned. A meta-analysis of randomized studies could not benefit from a routine ultrasound in the third trimester. The scientific purpose of this work is to evaluate the benefits of early detection and care of SGA (small for gestational age)/IUGR (growth-inhibited) fetuses and, if possible, to increase knowledge about this patient group. The hope is that this will lead to a better opportunity to personalize both preventive care and treatment of these women and children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2021

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

November 21, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 2, 2021

Completed
Last Updated

January 4, 2022

Status Verified

December 1, 2021

Enrollment Period

1.8 years

First QC Date

November 21, 2021

Last Update Submit

December 28, 2021

Conditions

Keywords

IUGRSGA

Outcome Measures

Primary Outcomes (1)

  • The frequency of newborns with an affected perinatal outcome (low Apgar score and or affected acid-base status at labor)

    Will the perinatal outcome at delivery( be measured as a low Apgar score at 5 minutes or an affected acid-base status in cord blood) be improved if IUGR(intrauterine growth restriction) is identified before labor

    2014-2017

Secondary Outcomes (1)

  • The frequency of newborns with an affected perinatal outcome (low Apgar score and or affected acid-base status at labor)(2)

    January 1th 2014- december 31th 2017

Study Arms (2)

Early / growth restriction

Intrauterine growth restriction with onset before 32 weeks of gestation

Procedure: ultrasound

Late growth restriction

Intrauterine growth restriction with onset after 32 weeks of gestation

Procedure: ultrasound

Interventions

ultrasoundPROCEDURE

An extra ultrasound performed during pregnancy

Early / growth restrictionLate growth restriction

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All pregnant women in Stockholm during 2014-2017

You may qualify if:

  • All pregnancies in Stockholm with a fetus, born between 2014 and 2017 and without chromosomal abnormalities or other serious structural abnormalities, will be included in the project.

You may not qualify if:

  • Pregnancies with known chromosomal abnormalities or other serious structural abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eva Wiberg-Itzel

Stockholm, 18239, Sweden

Location

MeSH Terms

Conditions

Fetal Growth Retardation

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Officials

  • Eva Wiberg-Itzel, PhD

    Karolinska Institute Sodersjukhuset Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

November 21, 2021

First Posted

December 2, 2021

Study Start

January 1, 2020

Primary Completion

October 30, 2021

Study Completion

October 30, 2021

Last Updated

January 4, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations